Aequus Pharmaceuticals Inc Asset Resilience Ratio

Latest as of March 2024: 4.11%

Aequus Pharmaceuticals Inc asset resilience ratio. Aequus Pharmaceuticals Inc (AQS) has an Asset Resilience Ratio of 4.11% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Aequus Pharmaceuticals Inc carry for a breakdown of total debt and financial obligations.

Liquid Assets

CA$44.85K

≈ $32.44K USD Cash + Short-term Investments

Total Assets

CA$1.09 Million

≈ $790.18K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Aequus Pharmaceuticals Inc (2017–2023)

Asset resilience ratio of Aequus Pharmaceuticals Inc from 2017 to 2023. This chart shows how Aequus Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. See Aequus Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Aequus Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Aequus Pharmaceuticals Inc.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$44.85K	4.11%
Total Liquid Assets	CA$44.85K	4.11%

Asset Resilience Insights

Limited Liquidity: Aequus Pharmaceuticals Inc maintains only 4.11% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Aequus Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio

Compare Aequus Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%
Zhejiang Medicine Co Ltd SHG:600216	Drug Manufacturers - Specialty & Generic	1.85%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%
Dezhan HealthCare Co Ltd SHE:000813	Drug Manufacturers - Specialty & Generic	0.09%
Chongqing Pharscin Pharmaceutical Co Ltd SHE:002907	Drug Manufacturers - Specialty & Generic	14.54%

Aequus Pharmaceuticals Inc Asset Resilience Ratio by Year (2017–2023)

Aequus Pharmaceuticals Inc asset resilience ratio by year from 2017 to 2023. The table below shows the annual Asset Resilience Ratio data for Aequus Pharmaceuticals Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	4.13%	CA$44.85K ≈ $32.44K	CA$1.09 Million ≈ $785.76K	+1.48pp
2022-12-31	2.65%	CA$44.85K ≈ $32.44K	CA$1.69 Million ≈ $1.22 Million	+1.62pp
2021-12-31	1.03%	CA$44.89K ≈ $32.47K	CA$4.35 Million ≈ $3.15 Million	+1.03pp
2020-12-31	0.00%	CA$123.00 ≈ $88.98	CA$3.13 Million ≈ $2.27 Million	-31.81pp
2017-12-31	31.81%	CA$850.00K ≈ $614.88K	CA$2.67 Million ≈ $1.93 Million	--

pp = percentage points

About Aequus Pharmaceuticals Inc

V:AQS Canada Drug Manufacturers - Specialty & Generic

Market Cap

$479.73K

CA$663.17K CAD

Market Cap Rank

#31093 Global

#1643 in Canada

Share Price

CA$0.01

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.01

All Time High

CA$0.69